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In a recent review article on gelastic seizures and hypothalamic hamartoma, 
Tellez-Zenteno and colleagues1 used the term, “status gelasticus” mostly correctly 
but referenced completely incorrectly the origins of the definition of this rare but 
becoming increasingly known phenomenon. This mistake followed upon an unusual 
oversight of quoting another author who had simply used the term and most certainly 
did not make any attempts to define it.2 We had initially published a case report of a 
30-month-old boy who underwent successful emergent transcallosal resection of his 
hypothalamic hamartoma for status gelasticus which lasted six weeks!3 In this report, 
we made clear mention that we labeled his “history of near-continuous gelastic seizures” 
as status gelasticus. Further discussion within this paper stated that although he was 
not strictly in status epilepticus (as he did regain full awareness between his seizures); 
his near-continuous gelastic seizure activity fully impaired the patient and his family. 
An update on this patient is that he had 90% seizure reduction (only a few gelastic 
seizures every two weeks) for 18 months after the surgery. He then underwent a second 
surgery: endoscopic resection of residual hypothalamic hamartoma and has now been 
seizure free for more than two years.
What was even more surprising about the mistake by Tellez-Zenteno and colleagues1 
is that they went on to reference the abovementioned paper as stating that our report3 
occurred subsequent to that by the other author.2 This was probably a simple mistake 
although an enquiry on PubMed clearly shows the chronological order of the two 
papers; not to mention the fact that they were both published in the same journal with 
our report several issues prior to the other.2,3 We have also clarified this previously in 
a publication entitled, “Coining of a new term, “status gelasticus” ”  4 where the term 
was finalized as referring to a prolonged cluster of gelastic seizures (ie, for more than 
20–30 minutes, a duration similar to that for status epilepticus) but without necessarily 
involving loss of awareness between seizures.4 Finally a subsequent paper5 referenced 
in the same section by Tellez-Zenteno and colleagues1 of a case report of a patient with 
levetiracetam-induced status gelasticus had previously correctly referenced the origin 
of the term, “status gelasticus”. All in all, these are the surprising circumstances of a 
simple oversight by Tellez-Zenteno and colleagues.1
Furthermore, Tellez-Zenteno and colleagues1 mention that in many cases 
extrahypothalamic coverage should be performed to evaluate spread of seizures and 
potential extratemporal onset as suggested by Cascino and colleagues.6 I believe this 
was exactly the opposite of what Cascino and colleagues6 were trying to convey. Neuropsychiatric Disease and Treatment 2009:5
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In their series, seven patients with hypothalamic hamartomas 
who underwent intracranial electroencephalography (EEG) 
monitoring and focal cortical resection (not hypothalamic 
hamartoma surgery) did not experience any improvement 
in their seizures. Since then it has become far clearer that 
in patients with hypothalamic hamartomas, the seizures and 
epilepsy emanate from there regardless of what the scalp 
EEG findings show. Intracranial EEG monitoring with 
rare exceptions should not be performed in hypothalamic 
hamartoma patients. Unfortunately we continue to see 
hypothalamic hamartoma patients referred from other insti-
tutions that have undergone one or more intracranial EEG 
monitoring and unsuccessful, tragic, subsequent focal cortical 
resections (frontal/temporal/parietal lobes) who were then 
subsequently cured by hypothalamic hamartoma resection. 
Although these beliefs are well known within “hypotha-
lamic hamartoma circles”, it is not as clear to the general 
neurology and epilepsy community and this knowledge must 
be disseminated.
Ergo more knowledge and education on gelastic seizures, 
status gelasticus and hypothalamic hamartomas should be 
welcome as this probably under-recognized condition is 
well-known to be either misdiagnosed, be very delayed 
in its diagnosis or often both which can be devastating 
as early (appropriate) surgical treatment is known to 
improve or prevent the frequently associated epileptic 
encephalopathy.7,8
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